MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Balance Sheets Overview
Current Ratio
4.66%
Quick Ratio
4.66%
Cash Ratio
0.00%
Debt to Asset Ratio
2143.97%
Unit: Dollar
Assets Breakdown
Accounts receivable, related par...
Cash
Prepaid expenses
Liabilities Breakdown
Retained earnings (deficit)
Additional paid in capital
Accrued expenses
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Balance Sheets
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Cash
239
271
4,578
69,555
Accounts receivable, related party
287,147
259,723
232,298
204,873
Prepaid expenses
200
200
200
200
Total current assets
287,587
260,194
237,076
274,628
Total assets
287,587
260,194
237,076
274,628
Accounts payable
20,618
20,150
11,024
1,714
Accrued expenses
2,007,987
1,985,896
1,852,221
1,838,230
Notes payable-Nonrelated Party
132,503
132,503
-
-
Notes payable-Related Party
32,963
8,926
132,504
191,339
Unearned income
1,243,692
1,275,331
1,306,971
1,338,611
Derivative liability
1,901,963
1,278,763
2,460,443
2,079,618
Convertible notes payable, net of unamortized debt discount
726,291
817,717
947,132
1,006,521
Other current liabilities
99,776
99,776
99,776
99,776
Total current liabilities
6,165,793
5,619,062
6,810,073
6,555,811
Total liabilities
6,165,793
5,619,062
6,810,073
6,555,811
Common stock (.0001 par value) 5,800,000,000 authorized and 1,129,988,004 and 39,374,704 shares issued and outstanding, respectively
112,999
35,144
10,806
3,939
Preferred stock, value-Series APreferred Stock
15,475
15,475
1,011
1,011
Preferred stock, value-Series MPreferred Stock
3
3
3
3
Preferred stock, value-Series NCPreferred Stock
2
2
2
2
Additional paid in capital
16,521,226
16,480,634
16,297,234
15,628,062
Other comprehensive income
-222,580
-222,580
-222,580
-222,580
Retained earnings (deficit)
-22,305,331
-21,667,546
-22,659,473
-21,691,620
Total stockholders equity (deficit)
-5,878,206
-5,358,868
-6,572,997
-6,281,183
Total liabilities & stockholders equity (deficit)
287,587
260,194
237,076
274,628
Page 1
Unit: Dollar. Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Balance Sheets
Accounts receivable,
related party
$287,147
(62.10%↑ Y/Y)
Cash
$239
(-86.43%↓ Y/Y)
Prepaid expenses
$200
(0.00%↑ Y/Y)
Total current assets
$287,587
(60.57%↑ Y/Y)
Total assets
$287,587
(46.10%↑ Y/Y)
Retained earnings
(deficit)
-$22,305,331
(-5.62%↓ Y/Y)
Other comprehensive
income
-$222,580
(-8.66%↓ Y/Y)
Total liabilities &
stockholders equity...
$287,587
(46.10%↑ Y/Y)
Total stockholders
equity (deficit)
-$5,878,206
(-1.07%↓ Y/Y)
Additional paid in capital
$16,521,226
(6.56%↑ Y/Y)
Common stock (.0001 par
value) 5,800,000,000...
$112,999
(3479.32%↑ Y/Y)
Preferred stock,
value-Series APreferred...
$15,475
(1430.66%↑ Y/Y)
Preferred stock,
value-Series MPreferred...
$3
(0.00%↑ Y/Y)
Preferred stock,
value-Series NCPreferred...
$2
(0.00%↑ Y/Y)
Total liabilities
$6,165,793
(2.55%↑ Y/Y)
Total current
liabilities
$6,165,793
(2.55%↑ Y/Y)
Accrued expenses
$2,007,987
(13.18%↑ Y/Y)
Derivative liability
$1,901,963
(6.83%↑ Y/Y)
Unearned income
$1,243,692
(-9.24%↓ Y/Y)
Convertible notes payable,
net of unamortized...
$726,291
(-5.66%↓ Y/Y)
Notes
payable-Nonrelated Party
$132,503
Other current
liabilities
$99,776
(375.12%↑ Y/Y)
Notes
payable-Related Party
$32,963
(-87.62%↓ Y/Y)
Accounts payable
$20,618
(-32.35%↓ Y/Y)
Buy us a coffee
Regen BioPharma Inc (RGBP)
Regen BioPharma Inc (RGBP)